Literature DB >> 16010495

Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives.

M Michael Cohen1.   

Abstract

Macroglossia, prenatal or postnatal overgrowth, and abdominal wall defects (omphalocele, umbilical hernia, or diastasis recti) permit early recognition of Beckwith-Wiedemann syndrome. Complications include neonatal hypoglycemia and an increased risk for Wilms tumor, adrenal cortical carcinoma, hepatoblastoma, rhabdomyosarcoma, and neuroblastoma, among others. Perinatal mortality can result from complications of prematurity, pronounced macroglossia, and rarely cardiomyopathy. The molecular basis of Beckwith-Wiedemann syndrome is complex, involving deregulation of imprinted genes found in 2 domains within the 11p15 region: telomeric Domain 1 (IGF2 and H19) and centromeric Domain 2 (KCNQ1, KCNQ1OT1, and CDKN1C). Topics discussed in this article are organized as a series of perspectives: general, historical, epidemiologic, clinical, pathologic, genetic/molecular, diagnostic, and differential diagnostic.

Entities:  

Mesh:

Year:  2005        PMID: 16010495     DOI: 10.1007/s10024-005-1154-9

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  29 in total

Review 1.  Maternal-fetal conflict, genomic imprinting and mammalian vulnerabilities to cancer.

Authors:  David Haig
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

2.  Cases of Beckwith-Wiedman Syndrome.

Authors:  K R Mohan; A K Simalti; M Kanitkar
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  (Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome.

Authors:  Alessandro Mussa; Silvia Russo; Agostina De Crescenzo; Andrea Freschi; Luciano Calzari; Silvia Maitz; Marina Macchiaiolo; Cristina Molinatto; Giuseppina Baldassarre; Milena Mariani; Luigi Tarani; Maria Francesca Bedeschi; Donatella Milani; Daniela Melis; Andrea Bartuli; Maria Vittoria Cubellis; Angelo Selicorni; Margherita Cirillo Silengo; Lidia Larizza; Andrea Riccio; Giovanni Battista Ferrero
Journal:  Eur J Hum Genet       Date:  2015-04-22       Impact factor: 4.246

Review 4.  Spinal adrenal cortical adenoma associated with Beckwith-Wiedemann syndrome: case report and review of the literature.

Authors:  Javier Giner; Isabel Esteban; Fernando Carceller; Javier Saceda; R M Regojo
Journal:  Childs Nerv Syst       Date:  2017-04-01       Impact factor: 1.475

5.  Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy Whitten; Adi L Tarca; Gaurav Bhatti; Sorin Draghici; Piya Chaemsaithong; Jezid Miranda; Sonia S Hassan
Journal:  J Perinat Med       Date:  2013-09-01       Impact factor: 1.901

Review 6.  Genetic considerations in the prenatal diagnosis of overgrowth syndromes.

Authors:  Neeta Vora; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2009-10       Impact factor: 3.050

7.  A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma.

Authors:  Fatemeh Abbaszadeh; Karen T Barker; Carmel McConville; Richard H Scott; Nazneen Rahman
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

Review 8.  Cardiometabolic health of children conceived by assisted reproductive technologies.

Authors:  Edwina H Yeung; Charlotte Druschel
Journal:  Fertil Steril       Date:  2013-01-08       Impact factor: 7.329

Review 9.  10 rare tumors that warrant a genetics referral.

Authors:  Kimberly C Banks; Jessica J Moline; Monica L Marvin; Anna C Newlin; Kristen J Vogel
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

Review 10.  What's new in metabolic and genetic hypoglycaemias: diagnosis and management.

Authors:  Vassili Valayannopoulos; Stéphane Romano; Karine Mention; Anne Vassault; Daniel Rabier; Michel Polak; Jean-Jacques Robert; Yves de Keyzer; Pascale de Lonlay
Journal:  Eur J Pediatr       Date:  2007-10-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.